Stocksigma LogoStocksigma Logo

Sotac Pharmaceuticals Reports Strong H1 FY27 Consolidated Results

Sotac Pharmaceuticals reported an 85.91% YoY increase in consolidated revenue from operations to ₹7,654.95 lakhs for the half year ended 30th Sep'26

Sotac Pharmaceuticals Reports Strong H1 FY27 Consolidated Results

Sotac Pharmaceuticals Ltd · Outcome · 13 Nov 2026, 11:57 pm

Sotac Pharmaceuticals Reports Strong H1 FY27 Consolidated Results Sotac Pharmaceuticals reported an 85.91% YoY increase in consolidated revenue from operations to ₹7,654.95 lakhs for the half year ended 30th Sep'26, compared to ₹4,117.61 lakhs in the previous year. Profit before tax rose 143.77% YoY to ₹817.07 lakhs from ₹335.18 lakhs. Consolidated net profit attributable to shareholders surged 117.12% YoY to ₹531.05 lakhs versus ₹244.59 lakhs in the corresponding period last year. Half-year basic and diluted EPS expanded to ₹4.81 from ₹2.21 YoY. Operating cash flow stood at ₹530.16 lakhs.

Original exchange filing (PDF)

More announcements from Sotac Pharmaceuticals Ltd

All Sotac Pharmaceuticals Ltd announcements